About Us Services Careers FAQ Contact Us 0
Home Medical Devices Global Pediatric Neurology Device Market Size, CAGR of 6.90%, Top Share, Forecast to 2032
Pediatric Neurology Device Market

Pediatric Neurology Device Market Size, Share & Trends Analysis Report By Product (Neurosurgery Devices, Neurostimulator, Cerebrospinal Fluid (CSF) Management Devices, Other), By Service and Treatment (Electroencephalogram, Intrathecal Baclofen Therapy, Neurological Evaluations, Vagal Nerve Stimulation), By Neurological Subspecialty (Neuro-Oncology, Neuromuscular, Neonatal Neurology, Neuro-Immunology, Stroke), By Age Group (Neonates, Infants, Children, Adolescents), By End-User (Hospital, Healthcare Center, Specialty Clinics, Neurological Research Centres), By Application (Brain Tumour, Epilepsy, Autism Spectrum Disorder, Parkinson’s Disease, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD54961DR
Last Updated : August 13, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pediatric Neurology Device Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    8. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurosurgery Devices
          1. By Value
        3. Neurostimulator
          1. By Value
        4. Cerebrospinal Fluid (CSF) Management Devices
          1. By Value
        5. Other
          1. By Value
      2. By Service and Treatment
        1. Introduction
          1. Service and Treatment By Value
        2. Electroencephalogram
          1. By Value
        3. Intrathecal Baclofen Therapy
          1. By Value
        4. Neurological Evaluations
          1. By Value
        5. Vagal Nerve Stimulation
          1. By Value
      3. By Neurological Subspecialty
        1. Introduction
          1. Neurological Subspecialty By Value
        2. Neuro-Oncology
          1. By Value
        3. Neuromuscular
          1. By Value
        4. Neonatal Neurology
          1. By Value
        5. Neuro-Immunology
          1. By Value
        6. Stroke
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Neonates
          1. By Value
        3. Infants
          1. By Value
        4. Children
          1. By Value
        5. Adolescents
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Healthcare Center
          1. By Value
        4. Specialty Clinics
          1. By Value
        5. Neurological Research Centres
          1. By Value
      6. By Application
        1. Introduction
          1. Application By Value
        2. Brain Tumour
          1. By Value
        3. Epilepsy
          1. By Value
        4. Autism Spectrum Disorder
          1. By Value
        5. Parkinson’s Disease
          1. By Value
        6. Others
          1. By Value
    9. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    8. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurosurgery Devices
          1. By Value
        3. Neurostimulator
          1. By Value
        4. Cerebrospinal Fluid (CSF) Management Devices
          1. By Value
        5. Other
          1. By Value
      2. By Service and Treatment
        1. Introduction
          1. Service and Treatment By Value
        2. Electroencephalogram
          1. By Value
        3. Intrathecal Baclofen Therapy
          1. By Value
        4. Neurological Evaluations
          1. By Value
        5. Vagal Nerve Stimulation
          1. By Value
      3. By Neurological Subspecialty
        1. Introduction
          1. Neurological Subspecialty By Value
        2. Neuro-Oncology
          1. By Value
        3. Neuromuscular
          1. By Value
        4. Neonatal Neurology
          1. By Value
        5. Neuro-Immunology
          1. By Value
        6. Stroke
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Neonates
          1. By Value
        3. Infants
          1. By Value
        4. Children
          1. By Value
        5. Adolescents
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Healthcare Center
          1. By Value
        4. Specialty Clinics
          1. By Value
        5. Neurological Research Centres
          1. By Value
      6. By Application
        1. Introduction
          1. Application By Value
        2. Brain Tumour
          1. By Value
        3. Epilepsy
          1. By Value
        4. Autism Spectrum Disorder
          1. By Value
        5. Parkinson’s Disease
          1. By Value
        6. Others
          1. By Value
    9. Germany
    10. France
    11. Spain
    12. Italy
    13. Russia
    14. Nordic
    15. Benelux
    16. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    8. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurosurgery Devices
          1. By Value
        3. Neurostimulator
          1. By Value
        4. Cerebrospinal Fluid (CSF) Management Devices
          1. By Value
        5. Other
          1. By Value
      2. By Service and Treatment
        1. Introduction
          1. Service and Treatment By Value
        2. Electroencephalogram
          1. By Value
        3. Intrathecal Baclofen Therapy
          1. By Value
        4. Neurological Evaluations
          1. By Value
        5. Vagal Nerve Stimulation
          1. By Value
      3. By Neurological Subspecialty
        1. Introduction
          1. Neurological Subspecialty By Value
        2. Neuro-Oncology
          1. By Value
        3. Neuromuscular
          1. By Value
        4. Neonatal Neurology
          1. By Value
        5. Neuro-Immunology
          1. By Value
        6. Stroke
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Neonates
          1. By Value
        3. Infants
          1. By Value
        4. Children
          1. By Value
        5. Adolescents
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Healthcare Center
          1. By Value
        4. Specialty Clinics
          1. By Value
        5. Neurological Research Centres
          1. By Value
      6. By Application
        1. Introduction
          1. Application By Value
        2. Brain Tumour
          1. By Value
        3. Epilepsy
          1. By Value
        4. Autism Spectrum Disorder
          1. By Value
        5. Parkinson’s Disease
          1. By Value
        6. Others
          1. By Value
    9. Korea
    10. Japan
    11. India
    12. Australia
    13. Singapore
    14. Taiwan
    15. South East Asia
    16. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    8. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurosurgery Devices
          1. By Value
        3. Neurostimulator
          1. By Value
        4. Cerebrospinal Fluid (CSF) Management Devices
          1. By Value
        5. Other
          1. By Value
      2. By Service and Treatment
        1. Introduction
          1. Service and Treatment By Value
        2. Electroencephalogram
          1. By Value
        3. Intrathecal Baclofen Therapy
          1. By Value
        4. Neurological Evaluations
          1. By Value
        5. Vagal Nerve Stimulation
          1. By Value
      3. By Neurological Subspecialty
        1. Introduction
          1. Neurological Subspecialty By Value
        2. Neuro-Oncology
          1. By Value
        3. Neuromuscular
          1. By Value
        4. Neonatal Neurology
          1. By Value
        5. Neuro-Immunology
          1. By Value
        6. Stroke
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Neonates
          1. By Value
        3. Infants
          1. By Value
        4. Children
          1. By Value
        5. Adolescents
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Healthcare Center
          1. By Value
        4. Specialty Clinics
          1. By Value
        5. Neurological Research Centres
          1. By Value
      6. By Application
        1. Introduction
          1. Application By Value
        2. Brain Tumour
          1. By Value
        3. Epilepsy
          1. By Value
        4. Autism Spectrum Disorder
          1. By Value
        5. Parkinson’s Disease
          1. By Value
        6. Others
          1. By Value
    9. Turkey
    10. Saudi Arabia
    11. South Africa
    12. Egypt
    13. Nigeria
    14. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Neurosurgery Devices
        1. By Value
      3. Neurostimulator
        1. By Value
      4. Cerebrospinal Fluid (CSF) Management Devices
        1. By Value
      5. Other
        1. By Value
    3. By Service and Treatment
      1. Introduction
        1. Service and Treatment By Value
      2. Electroencephalogram
        1. By Value
      3. Intrathecal Baclofen Therapy
        1. By Value
      4. Neurological Evaluations
        1. By Value
      5. Vagal Nerve Stimulation
        1. By Value
    4. By Neurological Subspecialty
      1. Introduction
        1. Neurological Subspecialty By Value
      2. Neuro-Oncology
        1. By Value
      3. Neuromuscular
        1. By Value
      4. Neonatal Neurology
        1. By Value
      5. Neuro-Immunology
        1. By Value
      6. Stroke
        1. By Value
    5. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Neonates
        1. By Value
      3. Infants
        1. By Value
      4. Children
        1. By Value
      5. Adolescents
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital
        1. By Value
      3. Healthcare Center
        1. By Value
      4. Specialty Clinics
        1. By Value
      5. Neurological Research Centres
        1. By Value
    7. By Application
      1. Introduction
        1. Application By Value
      2. Brain Tumour
        1. By Value
      3. Epilepsy
        1. By Value
      4. Autism Spectrum Disorder
        1. By Value
      5. Parkinson’s Disease
        1. By Value
      6. Others
        1. By Value
    8. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Neurosurgery Devices
          1. By Value
        3. Neurostimulator
          1. By Value
        4. Cerebrospinal Fluid (CSF) Management Devices
          1. By Value
        5. Other
          1. By Value
      2. By Service and Treatment
        1. Introduction
          1. Service and Treatment By Value
        2. Electroencephalogram
          1. By Value
        3. Intrathecal Baclofen Therapy
          1. By Value
        4. Neurological Evaluations
          1. By Value
        5. Vagal Nerve Stimulation
          1. By Value
      3. By Neurological Subspecialty
        1. Introduction
          1. Neurological Subspecialty By Value
        2. Neuro-Oncology
          1. By Value
        3. Neuromuscular
          1. By Value
        4. Neonatal Neurology
          1. By Value
        5. Neuro-Immunology
          1. By Value
        6. Stroke
          1. By Value
      4. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Neonates
          1. By Value
        3. Infants
          1. By Value
        4. Children
          1. By Value
        5. Adolescents
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital
          1. By Value
        3. Healthcare Center
          1. By Value
        4. Specialty Clinics
          1. By Value
        5. Neurological Research Centres
          1. By Value
      6. By Application
        1. Introduction
          1. Application By Value
        2. Brain Tumour
          1. By Value
        3. Epilepsy
          1. By Value
        4. Autism Spectrum Disorder
          1. By Value
        5. Parkinson’s Disease
          1. By Value
        6. Others
          1. By Value
    9. Mexico
    10. Argentina
    11. Chile
    12. Colombia
    13. Rest of LATAM
    1. Pediatric Neurology Device Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Medtronic
    3. Stryker Corporation
    4. Boston Scientific
    5. Braun
    6. Integra LifeSciences
    7. Nihon Kohden
    8. Natus Medical
    9. Cadwell Industries
    10. neurocare group AG
    11. Anuncia Medical Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.